Intensive Care Units (ICU): The clinical pharmacist role to improve clinical outcomes and reduce mortality rate- An undeniable function
Article Sidebar
Main Article Content
Abstract
Observing relevant biomedical literature we have see that clinical pharmacist play a crucial role in ICU settings with reducing in mortality rate and improving some clinical outcomes.
Article Details
Copyright (c) 2017 Luisetto M, et al.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Bond CA, Raehl CL, Franke T. Clinical pharmacy services and hospital mortality rates. Pharmacotherapy. 1999; 19: 556-564. Ref.: https://goo.gl/Awznez
Leape LL, Cullen DJ, Clapp MD, Burdick E, Demonaco HJ, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA. 1999; 282: 267-270. Ref.: https://goo.gl/E5z7zZ
Gentry CA, Greenfield RA, Slater LN, Wack M, Huycke MM. Outcomes of an antimicrobial control program in a teaching hospital. Am J Health Syst Pharm. 2000; 57: 268-274. Ref.: https://goo.gl/rnnfhT
Bond CA, Raehl CL, Franke T. Interrelationships among mortality rates, drug costs, total cost of care, and length of stay in United States hospitals: summary and recommendations for clinical pharmacy services and staffing. Pharmacotherapy. 2001; 21: 129-141. Ref.: https://goo.gl/zwF7uH
Kane SL, Weber RJ, Dasta JF. The impact of critical care pharmacists on enhancing patient outcomes. Intensive Care Med. 2003; 29: 691–698. Ref.: https://goo.gl/CGvWDY
Rothschild JM, Landrigan CP, Cronin JW, Kaushal R, Lockley SW, et al. The Critical Care Safety Study: The incidence and nature of adverse events and serious medical errors in intensive care. Crit Care Med. 2005 33: 1694-1700. Ref.: https://goo.gl/R9N59J
Bond CA, Raehl CL. Clinical pharmacy services, pharmacy staffing, and hospital mortality rates. Pharmacotherapy. 2007; 27: 481-493. Ref.: https://goo.gl/S7mk2n
MacLaren R, Bond CA. Effects of pharmacist participation in intensive care units on clinical and economic outcomes of critically ill patients with thromboembolic or infarction-related events. Pharmacotherapy. 2009; 29: 761-768. Ref.: https://goo.gl/CMXXjJ
MacLaren R, Bond CA, Martin SJ, Fike D. Clinical and economic outcomes of involving pharmacists in the direct care of critically ill patients with infections. Crit Care Med. 2008; 36: 3184-3189. Ref.: https://goo.gl/o5FZ1e
Valentin A, Capuzzo M, Guidet B, Moreno R, Metnitz B, et al. Errors in administration of parenteral drugs in intensive care units: multinational prospective study. BMJ. 2009; 338: 814. Ref.: https://goo.gl/oS8qF3
Chisholm-Burns MA, Kim Lee J, Spivey CA, Slack M, Herrier RN, et al. US pharmacists’ effect as team members on patient care: systematic review and meta-analyses. Med Care. 2010; 48: 923-933. Ref.: https://goo.gl/Jqsvsn
Shulman R, McKenzie CA, Landa J, Bourne RS, Jones A, et al. Pharmacist’s review and outcomes: Treatment-enhancing contributions tallied, evaluated, and documented (PROTECTED-UK). J Crit Care. 2015; 30: 808-813. Ref.: https://goo.gl/dBkmjb
Hisham M, Sivakumar MN, Veerasekar G. Impact of clinical pharmacist in an Indian Intensive Care Unit. Indian J Crit Care Med. 2016; 20: 78-83. Ref.: https://goo.gl/HcVc1D
Luisetto M, Nili-Ahmadabadi B, Mashori GR. The Clinical Pharmacists Main Focus. J Appl Pharm. 2017; 9: 114. Ref.: https://goo.gl/ZnwCis
Amine Ali Zeggwagh, HoudaMouad, TarekDendane, Khalid Abidi, JihaneBelayachi, et al. Preventability of death in a medical intensive care unit at a university hospital in a developing country. Indian J Crit Care Med. 2014; 18: 88-94. Ref.: https://goo.gl/8dY6SW
Dilip Kothari, Suman Gupta, Chetan Sharma, Saroj Kothari. Medication error in anaesthesia and critical care: A cause for concern. Indian J Anaesth. 2010; 54: 187-192. Ref.: https://goo.gl/KP6QTz
Eric Moyen, Eric Camiré, Stelfox HT. Clinical review: Medication errors in critical care. Crit Care. 2008; 12: 208. Ref.: https://goo.gl/9EN6f7
Fideles GM, de Alcântara-Neto JM, Peixoto Júnior AA, de Souza-Neto PJ, Tonete TL, et al. Pharmacist recommendations in an intensive care unit: three-year clinical activities. RevBras Ter Intensiva. 2015; 27: 149-154. Ref.: https://goo.gl/ZbB96T
Preslaski CR, Lat I, MacLaren R, Poston J. Pharmacist contributions as members of the multidisciplinary ICU team. Chest. 2013; 144: 1687-1695. Ref.: https://goo.gl/9WQFDg
Calloway S, Akilo HA, Bierman K. Impact of a clinical decision support system on pharmacy clinical interventions, documentation efforts, and costs. Hosp Pharm. 2013; 48: 744-752. Ref.: https://goo.gl/JmhKwL
Kucukarslan SN, Corpus K, Mehta N, Mlynarek M, Peters M, et al. Evaluation of a dedicated pharmacist staffing model in the medical intensive care unit. Hosp Pharm. 2013; 48: 922-930. Ref.: https://goo.gl/tJBG4G
Rudis MI, Brandl KM. Position paper on critical care pharmacy services. Society of Critical Care Medicine and American College of Clinical Pharmacy Task Force on Critical Care Pharmacy Services. Crit Care Med. 2000; 28: 3746-3750. Ref.: https://goo.gl/YzCco7
Randolph AG, Pronovost P. Reorganizing the delivery of intensive care could improve efficiency and save lives. J Eval Clin Pract. 2002; 8: 1-8. Ref.: https://goo.gl/PQWLHV
Kruer RM, Jarrell AS, Latif A. Reducing medication errors in critical care: a multimodal approach. Clin Pharmacol. 2014; 6: 117-126. Ref.: https://goo.gl/mTs4Ez
Emergency drug hospital cabinet systems practical experience-Piacenza (SIFO society of Italian hospital pharmacist Poster abstract) 2016 MILAN GIORNALE ITALIANO DI FARMACIA CLINICA, Acts of theXXXVII Congress National SIFO Milan. 2016.